In Situ Hybridization (ISH) Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: I75A2165AD7AEN
Market Monitor Global

Abstracts

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).

This report contains market size and forecasts of In Situ Hybridization (ISH) in Global, including the following market information:

Global In Situ Hybridization (ISH) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global In Situ Hybridization (ISH) market was valued at 996.1 million in 2021 and is projected to reach US$ 1307.4 million by 2028, at a CAGR of 4.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of In Situ Hybridization (ISH) include Thermo Fisher Scientific, Leica BiosystemsNussloch GmbH, BIOVIEW, Agilent Technologies, Merck KGaA, PerkinElmer Inc., Bio-Rad Laboratories Inc., NeoGenomics Laboratories Inc. and Advanced Cell Diagnostics Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In Situ Hybridization (ISH) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global In Situ Hybridization (ISH) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global In Situ Hybridization (ISH) Market Segment Percentages, by Type, 2021 (%)

• Instruments
• Kits & Probes
• Software
• Services

Global In Situ Hybridization (ISH) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global In Situ Hybridization (ISH) Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Cytogenetics
• Developmental Biology
• Infectious Diseases
• Others

Global In Situ Hybridization (ISH) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global In Situ Hybridization (ISH) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies In Situ Hybridization (ISH) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies In Situ Hybridization (ISH) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Leica BiosystemsNussloch GmbH
• BIOVIEW
• Agilent Technologies
• Merck KGaA
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• NeoGenomics Laboratories Inc.
• Advanced Cell Diagnostics Inc.
• Oxford Gene Technology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 In Situ Hybridization (ISH) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global In Situ Hybridization (ISH) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IN SITU HYBRIDIZATION (ISH) OVERALL MARKET SIZE

2.1 Global In Situ Hybridization (ISH) Market Size: 2021 VS 2028
2.2 Global In Situ Hybridization (ISH) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top In Situ Hybridization (ISH) Players in Global Market
3.2 Top Global In Situ Hybridization (ISH) Companies Ranked by Revenue
3.3 Global In Situ Hybridization (ISH) Revenue by Companies
3.4 Top 3 and Top 5 In Situ Hybridization (ISH) Companies in Global Market, by Revenue in 2021
3.5 Global Companies In Situ Hybridization (ISH) Product Type
3.6 Tier 1, Tier 2 and Tier 3 In Situ Hybridization (ISH) Players in Global Market
  3.6.1 List of Global Tier 1 In Situ Hybridization (ISH) Companies
  3.6.2 List of Global Tier 2 and Tier 3 In Situ Hybridization (ISH) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global In Situ Hybridization (ISH) Market Size Markets, 2021 & 2028
  4.1.2 Instruments
  4.1.3 Kits & Probes
  4.1.4 Software
  4.1.5 Services
4.2 By Type - Global In Situ Hybridization (ISH) Revenue & Forecasts
  4.2.1 By Type - Global In Situ Hybridization (ISH) Revenue, 2017-2022
  4.2.2 By Type - Global In Situ Hybridization (ISH) Revenue, 2023-2028
  4.2.3 By Type - Global In Situ Hybridization (ISH) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global In Situ Hybridization (ISH) Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Cytogenetics
  5.1.4 Developmental Biology
  5.1.5 Infectious Diseases
  5.1.6 Others
5.2 By Application - Global In Situ Hybridization (ISH) Revenue & Forecasts
  5.2.1 By Application - Global In Situ Hybridization (ISH) Revenue, 2017-2022
  5.2.2 By Application - Global In Situ Hybridization (ISH) Revenue, 2023-2028
  5.2.3 By Application - Global In Situ Hybridization (ISH) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global In Situ Hybridization (ISH) Market Size, 2021 & 2028
6.2 By Region - Global In Situ Hybridization (ISH) Revenue & Forecasts
  6.2.1 By Region - Global In Situ Hybridization (ISH) Revenue, 2017-2022
  6.2.2 By Region - Global In Situ Hybridization (ISH) Revenue, 2023-2028
  6.2.3 By Region - Global In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America In Situ Hybridization (ISH) Revenue, 2017-2028
  6.3.2 US In Situ Hybridization (ISH) Market Size, 2017-2028
  6.3.3 Canada In Situ Hybridization (ISH) Market Size, 2017-2028
  6.3.4 Mexico In Situ Hybridization (ISH) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe In Situ Hybridization (ISH) Revenue, 2017-2028
  6.4.2 Germany In Situ Hybridization (ISH) Market Size, 2017-2028
  6.4.3 France In Situ Hybridization (ISH) Market Size, 2017-2028
  6.4.4 U.K. In Situ Hybridization (ISH) Market Size, 2017-2028
  6.4.5 Italy In Situ Hybridization (ISH) Market Size, 2017-2028
  6.4.6 Russia In Situ Hybridization (ISH) Market Size, 2017-2028
  6.4.7 Nordic Countries In Situ Hybridization (ISH) Market Size, 2017-2028
  6.4.8 Benelux In Situ Hybridization (ISH) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia In Situ Hybridization (ISH) Revenue, 2017-2028
  6.5.2 China In Situ Hybridization (ISH) Market Size, 2017-2028
  6.5.3 Japan In Situ Hybridization (ISH) Market Size, 2017-2028
  6.5.4 South Korea In Situ Hybridization (ISH) Market Size, 2017-2028
  6.5.5 Southeast Asia In Situ Hybridization (ISH) Market Size, 2017-2028
  6.5.6 India In Situ Hybridization (ISH) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America In Situ Hybridization (ISH) Revenue, 2017-2028
  6.6.2 Brazil In Situ Hybridization (ISH) Market Size, 2017-2028
  6.6.3 Argentina In Situ Hybridization (ISH) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa In Situ Hybridization (ISH) Revenue, 2017-2028
  6.7.2 Turkey In Situ Hybridization (ISH) Market Size, 2017-2028
  6.7.3 Israel In Situ Hybridization (ISH) Market Size, 2017-2028
  6.7.4 Saudi Arabia In Situ Hybridization (ISH) Market Size, 2017-2028
  6.7.5 UAE In Situ Hybridization (ISH) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific In Situ Hybridization (ISH) Major Product Offerings
  7.1.4 Thermo Fisher Scientific In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Leica BiosystemsNussloch GmbH
  7.2.1 Leica BiosystemsNussloch GmbH Corporate Summary
  7.2.2 Leica BiosystemsNussloch GmbH Business Overview
  7.2.3 Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Major Product Offerings
  7.2.4 Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.2.5 Leica BiosystemsNussloch GmbH Key News
7.3 BIOVIEW
  7.3.1 BIOVIEW Corporate Summary
  7.3.2 BIOVIEW Business Overview
  7.3.3 BIOVIEW In Situ Hybridization (ISH) Major Product Offerings
  7.3.4 BIOVIEW In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.3.5 BIOVIEW Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies In Situ Hybridization (ISH) Major Product Offerings
  7.4.4 Agilent Technologies In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.4.5 Agilent Technologies Key News
7.5 Merck KGaA
  7.5.1 Merck KGaA Corporate Summary
  7.5.2 Merck KGaA Business Overview
  7.5.3 Merck KGaA In Situ Hybridization (ISH) Major Product Offerings
  7.5.4 Merck KGaA In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.5.5 Merck KGaA Key News
7.6 PerkinElmer Inc.
  7.6.1 PerkinElmer Inc. Corporate Summary
  7.6.2 PerkinElmer Inc. Business Overview
  7.6.3 PerkinElmer Inc. In Situ Hybridization (ISH) Major Product Offerings
  7.6.4 PerkinElmer Inc. In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.6.5 PerkinElmer Inc. Key News
7.7 Bio-Rad Laboratories Inc.
  7.7.1 Bio-Rad Laboratories Inc. Corporate Summary
  7.7.2 Bio-Rad Laboratories Inc. Business Overview
  7.7.3 Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Major Product Offerings
  7.7.4 Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.7.5 Bio-Rad Laboratories Inc. Key News
7.8 NeoGenomics Laboratories Inc.
  7.8.1 NeoGenomics Laboratories Inc. Corporate Summary
  7.8.2 NeoGenomics Laboratories Inc. Business Overview
  7.8.3 NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Major Product Offerings
  7.8.4 NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.8.5 NeoGenomics Laboratories Inc. Key News
7.9 Advanced Cell Diagnostics Inc.
  7.9.1 Advanced Cell Diagnostics Inc. Corporate Summary
  7.9.2 Advanced Cell Diagnostics Inc. Business Overview
  7.9.3 Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Major Product Offerings
  7.9.4 Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.9.5 Advanced Cell Diagnostics Inc. Key News
7.10 Oxford Gene Technology
  7.10.1 Oxford Gene Technology Corporate Summary
  7.10.2 Oxford Gene Technology Business Overview
  7.10.3 Oxford Gene Technology In Situ Hybridization (ISH) Major Product Offerings
  7.10.4 Oxford Gene Technology In Situ Hybridization (ISH) Revenue in Global Market (2017-2022)
  7.10.5 Oxford Gene Technology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. In Situ Hybridization (ISH) Market Opportunities & Trends in Global Market
Table 2. In Situ Hybridization (ISH) Market Drivers in Global Market
Table 3. In Situ Hybridization (ISH) Market Restraints in Global Market
Table 4. Key Players of In Situ Hybridization (ISH) in Global Market
Table 5. Top In Situ Hybridization (ISH) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global In Situ Hybridization (ISH) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global In Situ Hybridization (ISH) Revenue Share by Companies, 2017-2022
Table 8. Global Companies In Situ Hybridization (ISH) Product Type
Table 9. List of Global Tier 1 In Situ Hybridization (ISH) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In Situ Hybridization (ISH) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global In Situ Hybridization (ISH) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - In Situ Hybridization (ISH) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - In Situ Hybridization (ISH) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global In Situ Hybridization (ISH) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - In Situ Hybridization (ISH) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - In Situ Hybridization (ISH) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global In Situ Hybridization (ISH) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global In Situ Hybridization (ISH) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global In Situ Hybridization (ISH) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America In Situ Hybridization (ISH) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe In Situ Hybridization (ISH) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia In Situ Hybridization (ISH) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America In Situ Hybridization (ISH) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa In Situ Hybridization (ISH) Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific In Situ Hybridization (ISH) Product Offerings
Table 32. Thermo Fisher Scientific In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 33. Leica BiosystemsNussloch GmbH Corporate Summary
Table 34. Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Product Offerings
Table 35. Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 36. BIOVIEW Corporate Summary
Table 37. BIOVIEW In Situ Hybridization (ISH) Product Offerings
Table 38. BIOVIEW In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies In Situ Hybridization (ISH) Product Offerings
Table 41. Agilent Technologies In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 42. Merck KGaA Corporate Summary
Table 43. Merck KGaA In Situ Hybridization (ISH) Product Offerings
Table 44. Merck KGaA In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 45. PerkinElmer Inc. Corporate Summary
Table 46. PerkinElmer Inc. In Situ Hybridization (ISH) Product Offerings
Table 47. PerkinElmer Inc. In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 48. Bio-Rad Laboratories Inc. Corporate Summary
Table 49. Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Product Offerings
Table 50. Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 51. NeoGenomics Laboratories Inc. Corporate Summary
Table 52. NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Product Offerings
Table 53. NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 54. Advanced Cell Diagnostics Inc. Corporate Summary
Table 55. Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Product Offerings
Table 56. Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)
Table 57. Oxford Gene Technology Corporate Summary
Table 58. Oxford Gene Technology In Situ Hybridization (ISH) Product Offerings
Table 59. Oxford Gene Technology In Situ Hybridization (ISH) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. In Situ Hybridization (ISH) Segment by Type in 2021
Figure 2. In Situ Hybridization (ISH) Segment by Application in 2021
Figure 3. Global In Situ Hybridization (ISH) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global In Situ Hybridization (ISH) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global In Situ Hybridization (ISH) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In Situ Hybridization (ISH) Revenue in 2021
Figure 8. By Type - Global In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 9. By Application - Global In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 10. By Region - Global In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 11. By Country - North America In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 12. US In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 16. Germany In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 17. France In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 24. China In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 28. India In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 30. Brazil In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa In Situ Hybridization (ISH) Revenue Market Share, 2017-2028
Figure 33. Turkey In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE In Situ Hybridization (ISH) Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BIOVIEW In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Agilent Technologies In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck KGaA In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. PerkinElmer Inc. In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Oxford Gene Technology In Situ Hybridization (ISH) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)